Literature DB >> 16913709

Calcium channel antagonists discovered by a multidisciplinary approach.

Emanuele Carosati1, Gabriele Cruciani, Alberto Chiarini, Roberta Budriesi, Pierfranco Ioan, Raffaella Spisani, Domenico Spinelli, Barbara Cosimelli, Fabio Fusi, Maria Frosini, Rosanna Matucci, Francesco Gasparrini, Alessia Ciogli, Philip J Stephens, Frank J Devlin.   

Abstract

A multidisciplinary project has led to the discovery of novel, structurally diverse, L-type calcium entry blockers (CEBs). The absolute configuration of a recently reported CEB has been determined by vibrational circular dichroism spectroscopy, to assign the stereospecificity of the ligand-channel interaction. Thereafter, a virtual screening procedure was performed with the aim of identifying novel chemotypes for CEBs, starting from a database of purchasable compounds; 340,000 molecules were screened in silico in order to prioritize structures of interest for bioscreening. As a result, 20 compounds were tested in vitro, and functional and binding assays revealed several hits with promising behavior as CEBs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16913709     DOI: 10.1021/jm0604373

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  A novel approach for predicting P-glycoprotein (ABCB1) inhibition using molecular interaction fields.

Authors:  Fabio Broccatelli; Emanuele Carosati; Annalisa Neri; Maria Frosini; Laura Goracci; Tudor I Oprea; Gabriele Cruciani
Journal:  J Med Chem       Date:  2011-02-22       Impact factor: 7.446

2.  Lubeluzole: from anti-ischemic drug to preclinical antidiarrheal studies.

Authors:  Maria Maddalena Cavalluzzi; Roberta Budriesi; Maria Antonietta De Salvia; Laura Quintieri; Monica Piarulli; Gualtiero Milani; Roberta Gualdani; Matteo Micucci; Ivan Corazza; Antonio Rosato; Maurizio Viale; Leonardo Caputo; Carlo Franchini; Giovanni Lentini
Journal:  Pharmacol Rep       Date:  2020-10-19       Impact factor: 3.024

3.  Reduced density gradient as a novel approach for estimating QSAR descriptors, and its application to 1, 4-dihydropyridine derivatives with potential antihypertensive effects.

Authors:  Christiaan Jardínez; Alberto Vela; Julián Cruz-Borbolla; Rodrigo J Alvarez-Mendez; José G Alvarado-Rodríguez
Journal:  J Mol Model       Date:  2016-11-26       Impact factor: 1.810

4.  ABCB1 Structural Models, Molecular Docking, and Synthesis of New Oxadiazolothiazin-3-one Inhibitors.

Authors:  Camillo Rosano; Maurizio Viale; Barbara Cosimelli; Elda Severi; Rosaria Gangemi; Alessia Ciogli; Daniela De Totero; Domenico Spinelli
Journal:  ACS Med Chem Lett       Date:  2013-05-13       Impact factor: 4.345

5.  Determination of Absolute Configuration of Natural Products: Theoretical Calculation of Electronic Circular Dichroism as a Tool.

Authors:  Xing-Cong Li; Daneel Ferreira; Yuanqing Ding
Journal:  Curr Org Chem       Date:  2010-10-01       Impact factor: 2.180

6.  3-Aryl-4-nitrobenzothiochromans S,S-dioxide: From Calcium-Channel Modulators Properties to Multidrug-Resistance Reverting Activity.

Authors:  Matteo Micucci; Maurizio Viale; Alberto Chiarini; Domenico Spinelli; Maria Frosini; Cinzia Tavani; Massimo Maccagno; Lara Bianchi; Rosaria Gangemi; Roberta Budriesi
Journal:  Molecules       Date:  2020-02-27       Impact factor: 4.411

7.  Sweet chestnut (Castanea sativa Mill.) bark extract: cardiovascular activity and myocyte protection against oxidative damage.

Authors:  Alberto Chiarini; Matteo Micucci; Marco Malaguti; Roberta Budriesi; Pierfranco Ioan; Monia Lenzi; Carmela Fimognari; Tullia Gallina Toschi; Patrizia Comandini; Silvana Hrelia
Journal:  Oxid Med Cell Longev       Date:  2013-02-27       Impact factor: 6.543

8.  Curcuma longa L. as a therapeutic agent in intestinal motility disorders. 2: Safety profile in mouse.

Authors:  Matteo Micucci; Rita Aldini; Monica Cevenini; Carolina Colliva; Silvia Spinozzi; Giulia Roda; Marco Montagnani; Cecilia Camborata; Luca Camarda; Alberto Chiarini; Giuseppe Mazzella; Roberta Budriesi
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.